R
Richard Bax
Researcher at British Society for Antimicrobial Chemotherapy
Publications - 8
Citations - 1169
Richard Bax is an academic researcher from British Society for Antimicrobial Chemotherapy. The author has contributed to research in topics: Pharmacist & Cost–benefit analysis. The author has an hindex of 7, co-authored 8 publications receiving 1004 citations. Previous affiliations of Richard Bax include University of Nottingham.
Papers
More filters
Journal ArticleDOI
Alternatives to antibiotics—a pipeline portfolio review
Lloyd George Czaplewski,Richard Bax,Martha R. J. Clokie,Michael J. Dawson,Heather Fairhead,Vincent A. Fischetti,Simon J. Foster,Brendan Gilmore,Robert E. W. Hancock,David R Harper,Ian R. Henderson,Kai Hilpert,Brian V. Jones,Brian V. Jones,Aras Kadioglu,David Knowles,Sigríður Ólafsdóttir,David J. Payne,Steve Projan,Sunil Shaunak,Jared Silverman,Christopher M. Thomas,Trevor J. Trust,Peter Warn,John H. Rex +24 more
TL;DR: This first wave of alternatives to antibiotics will probably best serve as adjunctive or preventive therapies, which suggests that conventional antibiotics are still needed.
Journal ArticleDOI
Discovery research: the scientific challenge of finding new antibiotics
David M. Livermore,Martin J. Blaser,Otto Carrs,Gail H. Cassell,Neil O. Fishman,Robert Guidos,Stuart B. Levy,John H. Powers,Ragnar Norrby,Glenn S. Tillotson,Rick Davies,Steven J. Projan,Michael J. Dawson,Dominique L Monnet,Marcus Keogh-Brown,Kieran Hand,Sarah Garner,David Findlay,Chantal M. Morel,Richard Wise,Richard Bax,Frances Burke,Ian Chopra,Lloyd George Czaplewski,Roger Finch,Livermore David,Laura J. V. Piddock,Tony White +27 more
TL;DR: Although a raft of start-up companies are now finding new antibiotic compounds, their development through Phase III depends on financial commitments from large pharmaceutical companies, where the discouraging regulatory environment and the poor likely return on investment remain paramount issues.
Journal ArticleDOI
The urgent need for new antibacterial agents
Richard Wise,Martin Blaser,Otto Carrs,Gail Cassell,Neil Fishman,Robert Guidos,Stuart Levy,John H. Powers,Ragnar Norrby,Glenn S. Tillotson,Rick Davies,Steven J. Projan,Michael J. Dawson,Dominique Monnet,Marcus Keogh-Brown,Kieran Hand,Sarah Garner,David Findlay,Chantal M. Morel,Richard Bax,Frances Burke,Ian Chopra,Lloyd George Czaplewski,Roger Finch,David Livermore,Laura J. V. Piddock,Tony White +26 more
TL;DR: Rather than restate the concerns surrounding antimicrobial resistance, its surveillance and how it might be contained, the BSAC adopted a different approach, focusing on the barriers to discovery and development of new technologies that might combat resistance (including new antimicrobial agents) and how these might be overcome.
Journal ArticleDOI
Effective antibacterials: at what cost? The economics of antibacterial resistance and its control
Anthony R. White,Martin J. Blaser,Otto Carrs,Gail H. Cassell,Neil O. Fishman,Robert Guidos,Stuart B. Levy,John H. Powers,Ragnar Norrby,Glenn S. Tillotson,Rick Davies,Steven J. Projan,Michael J. Dawson,Dominique L Monnet,Marcus Keogh-Brown,Kieran Hand,Sarah Garner,David Findlay,Chantal M. Morel,Richard Wise,Richard Bax,Frances Burke,Ian Chopra,Lloyd George Czaplewski,Roger Finch,David M. Livermore,Laura J. V. Piddock,Tony White +27 more
TL;DR: The development and economic model of antibacterial use needs to be rebuilt based on this value through dialogue with the various stakeholders, including the pharmaceutical industry, and alternative incentives from 'push' to 'pull' and funding models, such as public/private partnerships, agreed.
Working Party Report Self-medication of antibacterials without prescription (also called 'over-the-counter' use) A report of a Working Party of the British Society for Antimicrobial Chemotherapy
David S. Reeves,Roger Finch,Richard Bax,Peter Davey,Alan Li,Wan Po,Geeta Lingam,Stephen G. Mann,Michael A. L. Pringle,Glaxo Wellcome +9 more
TL;DR: In this paper, the authors discuss the use of antimicrobial agents for self-medication and their use in the Patient Information Leaflet (PIL) and make recommendations for improving the situation.